Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points
BackgroundNonadherence produces considerable health consequences and economic burden to patients and payers. One approach to improve medication nonadherence that has gained interest in recent years is the use of smartphone adherence apps. The development of smartphone adherence apps has increased ra...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2017-04-01
|
Series: | JMIR mHealth and uHealth |
Online Access: | http://mhealth.jmir.org/2017/4/e45/ |
_version_ | 1818900398676639744 |
---|---|
author | Dayer, Lindsey E Shilling, Rebecca Van Valkenburg, Madalyn Martin, Bradley C Gubbins, Paul O Hadden, Kristie Heldenbrand, Seth |
author_facet | Dayer, Lindsey E Shilling, Rebecca Van Valkenburg, Madalyn Martin, Bradley C Gubbins, Paul O Hadden, Kristie Heldenbrand, Seth |
author_sort | Dayer, Lindsey E |
collection | DOAJ |
description | BackgroundNonadherence produces considerable health consequences and economic burden to patients and payers. One approach to improve medication nonadherence that has gained interest in recent years is the use of smartphone adherence apps. The development of smartphone adherence apps has increased rapidly since 2012; however, literature evaluating the clinical app and effectiveness of smartphone adherence apps to improve medication adherence is generally lacking.
ObjectiveThe aims of this study were to (1) provide an updated evaluation and comparison of medication adherence apps in the marketplace by assessing the features, functionality, and health literacy (HL) of the highest-ranking adherence apps and (2) indirectly measure the validity of our rating methodology by determining the relationship between our app evaluations and Web-based consumer ratings.
MethodsTwo independent reviewers assessed the features and functionality using a 4-domain rating tool of all adherence apps identified based on developer claims. The same reviewers downloaded and tested the 100 highest-ranking apps including an additional domain for assessment of HL. Pearson product correlations were estimated between the consumer ratings and our domain and total scores.
ResultsA total of 824 adherence apps were identified; of these, 645 unique apps were evaluated after applying exclusion criteria. The median initial score based on descriptions was 14 (max of 68; range 0-60). As a result, 100 of the highest-scoring unique apps underwent user testing. The median overall user-tested score was 31.5 (max of 73; range 0-60). The majority of the user tested the adherence apps that underwent user testing reported a consumer rating score in their respective online marketplace. The mean consumer rating was 3.93 (SD 0.84). The total user-tested score was positively correlated with consumer ratings (r=.1969, P=.04).
ConclusionsMore adherence apps are available in the Web-based marketplace, and the quality of these apps varies considerably. Consumer ratings are positively but weakly correlated with user-testing scores suggesting that our rating tool has some validity but that consumers and clinicians may assess adherence app quality differently. |
first_indexed | 2024-12-19T20:03:14Z |
format | Article |
id | doaj.art-8a3f5cc5bbea46c58167ebe4035ccbd0 |
institution | Directory Open Access Journal |
issn | 2291-5222 |
language | English |
last_indexed | 2024-12-19T20:03:14Z |
publishDate | 2017-04-01 |
publisher | JMIR Publications |
record_format | Article |
series | JMIR mHealth and uHealth |
spelling | doaj.art-8a3f5cc5bbea46c58167ebe4035ccbd02022-12-21T20:07:36ZengJMIR PublicationsJMIR mHealth and uHealth2291-52222017-04-0154e4510.2196/mhealth.6582Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage PointsDayer, Lindsey EShilling, RebeccaVan Valkenburg, MadalynMartin, Bradley CGubbins, Paul OHadden, KristieHeldenbrand, SethBackgroundNonadherence produces considerable health consequences and economic burden to patients and payers. One approach to improve medication nonadherence that has gained interest in recent years is the use of smartphone adherence apps. The development of smartphone adherence apps has increased rapidly since 2012; however, literature evaluating the clinical app and effectiveness of smartphone adherence apps to improve medication adherence is generally lacking. ObjectiveThe aims of this study were to (1) provide an updated evaluation and comparison of medication adherence apps in the marketplace by assessing the features, functionality, and health literacy (HL) of the highest-ranking adherence apps and (2) indirectly measure the validity of our rating methodology by determining the relationship between our app evaluations and Web-based consumer ratings. MethodsTwo independent reviewers assessed the features and functionality using a 4-domain rating tool of all adherence apps identified based on developer claims. The same reviewers downloaded and tested the 100 highest-ranking apps including an additional domain for assessment of HL. Pearson product correlations were estimated between the consumer ratings and our domain and total scores. ResultsA total of 824 adherence apps were identified; of these, 645 unique apps were evaluated after applying exclusion criteria. The median initial score based on descriptions was 14 (max of 68; range 0-60). As a result, 100 of the highest-scoring unique apps underwent user testing. The median overall user-tested score was 31.5 (max of 73; range 0-60). The majority of the user tested the adherence apps that underwent user testing reported a consumer rating score in their respective online marketplace. The mean consumer rating was 3.93 (SD 0.84). The total user-tested score was positively correlated with consumer ratings (r=.1969, P=.04). ConclusionsMore adherence apps are available in the Web-based marketplace, and the quality of these apps varies considerably. Consumer ratings are positively but weakly correlated with user-testing scores suggesting that our rating tool has some validity but that consumers and clinicians may assess adherence app quality differently.http://mhealth.jmir.org/2017/4/e45/ |
spellingShingle | Dayer, Lindsey E Shilling, Rebecca Van Valkenburg, Madalyn Martin, Bradley C Gubbins, Paul O Hadden, Kristie Heldenbrand, Seth Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points JMIR mHealth and uHealth |
title | Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points |
title_full | Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points |
title_fullStr | Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points |
title_full_unstemmed | Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points |
title_short | Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points |
title_sort | assessing the medication adherence app marketplace from the health professional and consumer vantage points |
url | http://mhealth.jmir.org/2017/4/e45/ |
work_keys_str_mv | AT dayerlindseye assessingthemedicationadherenceappmarketplacefromthehealthprofessionalandconsumervantagepoints AT shillingrebecca assessingthemedicationadherenceappmarketplacefromthehealthprofessionalandconsumervantagepoints AT vanvalkenburgmadalyn assessingthemedicationadherenceappmarketplacefromthehealthprofessionalandconsumervantagepoints AT martinbradleyc assessingthemedicationadherenceappmarketplacefromthehealthprofessionalandconsumervantagepoints AT gubbinspaulo assessingthemedicationadherenceappmarketplacefromthehealthprofessionalandconsumervantagepoints AT haddenkristie assessingthemedicationadherenceappmarketplacefromthehealthprofessionalandconsumervantagepoints AT heldenbrandseth assessingthemedicationadherenceappmarketplacefromthehealthprofessionalandconsumervantagepoints |